The expression of PAC1 increases in the degenerative thymus and low dose PACAP protects female mice from cyclophosphamide induced thymus atrophy

Peptides

Volumn 38, Issue 2, 2012, Pages 337-343

  Zhang, Huahua ^a   Yu, Rongjie ^b   Liu, Xiaofei ^b   Guo, Xiaoling ^b   Zeng, Zhixing ^b  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b JINAN UNIVERSITY   (China)

Author keywords

Cyclophosphamide; PAC1; Pituitary adenylate cyclase activating polypeptide (PACAP); Thymus

Indexed keywords

CASPASE 3; CYCLOPHOSPHAMIDE; DUAL SPECIFICITY PHOSPHATASE 2; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; LOW DRUG DOSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEX DIFFERENCE; SEXUAL DEVELOPMENT; THYMUS; THYMUS ATROPHY;

ANIMALS; APOPTOSIS; ATROPHY; CASPASES; CYCLOPHOSPHAMIDE; FEMALE; MALE; MICE; MICE, INBRED STRAINS; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE, TYPE I; THYMUS GLAND;

MUS;

EID: 84868702044     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2012.09.009     Document Type: Article

References (31)

1. C. Abad, C. Martinez, J. Leceta, M.G. Juarranz, M. Delgado, and R.P. Gomariz Pituitary adenylate-cyclase-activating polypeptide expression in the immune system Neuroimmunomodulation 10 2002 177 186
2. K.K. Aenlle, A. Kumar, L. Cui, T.C. Jackson, and T.C. Foster Estrogen effects on cognition and hippocampal transcription in middle-aged mice Neurobiol Aging 30 2009 932 945
3. S. Bourgault, D. Vaudry, A. Dejda, N.D. Doan, H. Vaudry, and A. Fournier Pituitary adenylate cyclase-activating polypeptide: focus on structure-activity relationships of a neuroprotective peptide Curr Med Chem 16 2009 4462 4480
4. T.C. Chao Female sex hormones and the immune system Changgeng Yi Xue Za Zhi 19 1996 95 106
5. N. Delcourt, E. Thouvenot, B. Chanrion, N. Galéotti, P. Jouin, and J. Bockaert PACAP type I receptor transactivation is essential for IGF-1 receptor signalling and antiapoptotic activity in neurons EMBO J 26 2007 1542 1551
6. M. Delgado, M. De la Fuente, C. Martínez, and R.P. Gomariz Pituitary adenylate cyclase-activating polypeptides (PACAP27 and PACAP38) inhibit the mobility of murine thymocytes and splenic lymphocytes: comparison with VIP and implication of cAMP J Neuroimmunol 62 1995 137 146
7. M. Delgado, and D. Ganea Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit antigen-induced apoptosis of mature T lymphocytes by inhibiting Fas ligand expression J Immunol 164 2000 1200 1210
8. M. Delgado, E. Garrido, C. Martinez, J. Leceta, and R.P. Gomariz Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptides (PACAP27) and (PACAP38) protect CD4+ CD8+ thymocytes from glucocorticoid-induced apoptosis Blood 87 1996 5152 5161
9. M. Delgado, J. Leceta, and R.P. Gomariz Function of PACAP in the immune system Endocr Updat 20 2003 305 322
10. Y. Ding, H. Cheng, R. Yu, C. Tang, X. Liu, and J. Chen Effects of cyclopeptide C*HSDGIC* from the cyclization of PACAP (1-5) on the proliferation and UVB-induced apoptosis of the retinal ganglion cell line RGC-5 Peptides 36 2012 280 285
11. B.M. Girard, A. Wolf-Johnston, K.M. Braas, L.A. Birder, V. May, and M.A. Vizzard PACAP-mediated ATP release from rat urothelium and regulation of PACAP/VIP and receptor mRNA in micturition pathways after cyclophosphamide (CYP)-induced cystitis J Mol Neurosci 36 2008 310 320
12. S. Giunta, A. Castorina, C. Bucolo, G. Magro, F. Drago, and V. D'Agata Early changes in pituitary adenylate cyclase-activating peptide, vasoactive intestinal peptide and related receptors expression in retina of streptozotocin-induced diabetic rats Peptides 37 1 2012 32 39
13. A.J. Harmar, A. Arimura, I. Gozes, L. Journot, M. Laburthe, and J.R. Pisegna International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclaseactivating polypeptide Pharmacol Rev 50 1998 265 270
14. Z. Helyes, G. Pozsgai, R. Börzsei, J. Németh, T. Bagoly, and L. Márk Inhibitory effect of PACAP-38 on acute neurogenic and non-neurogenic inflammatory processes in the rat Peptides 28 2007 1847 1855
15. M.L. Lara-Marquez, M.S. O'Dorisio, and B. Karacay Vasoactive intestinal peptide (VIP) receptor type 2 (VPAC2) is the predominant receptor expressed in human thymocytes Ann NY Acad Sci 921 2000 45 54
16. O. Masmoudi-Kouki, S. Douiri, Y. Hamdi, H. Kaddour, S. Bahdoudi, and D. Vaudry Pituitary adenylate cyclase-activating polypeptide protects astroglial cells against oxidative stress-induced apoptosis J Neurochem 117 2011 403 411
17. A. Miyata, A. Arimura, R.R. Dahl, N. Minamino, A. Uehara, and L. Jiang Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells Biochem Biophys Res Commun 164 1989 567 574
18. A. Miyata, L. Jiang, R.D. Dahl, C. Kitada, K. Kubo, and M. Fujino Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38) Biochem Biophys Res Commun 170 1989 643 648
19. N.J. Olsen, G. Olson, S.M. Viselli, X. Gu, and W.J. Kovacs Androgen receptors in thymic epithelium modulate thymus size and thymocyte development Endocrinology 142 2001 1278 1283
20. N.J. Olsen, S.M. Viselli, J. Fan, and W.J. Kovacs Androgens accelerate thymocyte apoptosis Endocrinology 139 1998 748 752
21. D. Reglodi, P. Kiss, A. Lubics, and A. Tamas Review on the protective effects of PACAP in models of neurodegenerative diseases in vitro and in vivo Curr Pharm Des 17 2011 962 972
22. K.J. Ressler, K.B. Mercer, B. Bradley, T. Jovanovic, A. Mahan, and K. Kerley Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor Nature 470 2011 492 497
23. T. Seaborn, O. Masmoudi-Kouli, A. Fournier, H. Vaudry, and D. Vaudry Protective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) against apoptosis Curr Pharm Des 17 2011 204 214
24. Y. Shneider, Y. Shtrauss, G. Yadid, and A. Pinhasov Differential expression of PACAP receptors in postnatal rat brain Neuropeptides 44 2010 509 514
25. H. Tang, L. Sun, Z. Xin, and D. Ganea Down-regulation of cytokine expression in murine lymphocytes by PACAP and VIP Ann NY Acad Sci 805 1996 768 778
26. N. Tokuda, Y. Arudchelvan, T. Sawada, Y. Adachi, T. Fukumoto, and M. Yasuda PACAP receptor (PAC1-R) expression in rat and rhesus monkey thymus Ann NY Acad Sci 1070 2006 581 585
27. N. Tokuda, K. Hamasaki, N. Mizutani, Y. Adachi, T. Sawada, and H. Funahashi Expression of PAC1 receptor in rat thymus after irradiation Regul Pept 123 2004 167 172
28. A. Vaudry, S. Falluel-Morel, M. Bourgault, D. Basille, O. Burel, and A. Wurtz Pituitary adenylate cyclase activating polypeptide and its receptors: 20 years after the discovery Pharmacol Rev 61 2009 283 357
29. E.E. Vomhof-DeKrey, A.R. Sandy, J.J. Failing, R.J. Hermann, S.A. Hoselton, and J.M. Schuh Radical reversal of vasoactive intestinal peptide (VIP) receptors during early lymphopoiesis Peptides 32 2011 2058 2066
30. G.J. Wang, and L. Cai Relatively low-dose cyclophosphamide is likely to induce apoptotic cell death in rat thymus through Fas/Fas ligand pathway Mutat Res 427 1999 125 133
31. X.J. Wei, T.J. Hu, J.R. Chen, and Y.Y. Wei Inhibitory effect of carboxymethylpachymaran on cyclophosphamide-induced oxidative stress in mice Int J Biol Macromol 49 2011 801 805